These findings underscore the need to better understand whether earlier phosphorus management influences morbidity and mortality in advanced CKD, according to researchers.
A significant proportion of children with chronic kidney disease (CKD) have unsuspected chromosomal imbalances.
Over 12 months, the exercise intervention increased participants' activity level by 2 or more metabolic equivalents.
Guidelines currently don't recognize gout as a risk factor for CKD and nephrolithiasis.
The incidence of gout among CKD patients was 6.82 per 1,000 persons per year compared to 2.43 for those without the disease.
Researchers compared 3 screening approaches for their ability to detect chronic kidney disease cases, and identify patients with higher rates of cardiovascular events and kidney decline.
Achieving an exercise capacity of more than 6.5 metabolic equivalents - such as daily brisk walking for 30-40 minutes -- might be protective, according to researchers.
Individuals who perceived the benefits of a low-phosphorus diet and demonstrated self-efficacy were more likely to make strides against hyperphosphatemia.
Reducing dietary phosphorus is challenging, so researchers have developed a food pyramid for CKD and dialysis patients.
The risk is particularly elevated for patients who have CKD risk factors, such as hypertension, diabetes, and older age.
When the kidneys are not working well, potassium levels in the blood can rise.
Hypo- and hyperkalemia found to increase death risk by 26% and 22%, respectively.
Calcification in the media of arteries may be a useful measure for screening.
Researchers found 88% higher odds of negative pregnancy outcomes for women with stage 1 CKD and no classic risk factors.
Simulation model projects that chronic kidney disease (CKD) prevalence will rise from 13.2% currently to nearly 17% by 2030.
Sodium zirconium cyclosilicate and patiromer hold promise as hyperkalemia treatments.
Physicians provided details of the first successful delivery of renal replacement therapy (RRT) to a patient with Ebola.
Calciphylaxis was 75% less likely to develop in patients who received the drug rather than placebo.
Each 0.5 mg/dL increment in serum phosphorus associated with 58% increased odds of coronary heart failure (CHF).
Renal events are significantly less likely if erythropoiesis-stimulating agents are started at hemoglobin levels below 11 g/dL.
Tight blood pressure control slows the rate of increase in total kidney volume and reduces left ventricular index.
Periodontal disease is associated with a significant 4.2-fold greater incidence of chronic kidney disease (CKD).
Plant-based diet had the lowest urinary phosphorus excretion, whereas an inorganic-based diet had the highest.
In a study of 3.3 million veterans, administration of niacin B vitamin was associated with less rapid decline in eGFR.
No association between phosphorus levels and all-cause mortality in women.
No link between overweight and the birth of babies with congenital abnormalities of the kidney and urinary tract.
Hemoglobin level below 8 mg/dL associated with 82% increased odds of prolonged bleeding time with anemia.
Beneficial effect of drug that inhibits galectin-3 is most pronounced in patients with diabetes-related chronic kidney disease (CKD).
Muscle mass is not as accurate a predictor of chronic kidney disease (CKD) as previously believed.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)